In the present study, we analysed SHON protein expression in a large cohort of breast tumours by immunohistochemical (IHC) staining using a newly generated anti-SHON monoclonal antibody and determined the relationship of SHON expression with the clinical outcome of chemotherapy-treated patients in another two independent cohorts. This evidence concerns the gene HIP1 and breast neoplasm.